|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Leemans CR, Braakhuis BJ and Brakenhoff
RH: The molecular biology of head and neck cancer. Nat Rev Cancer.
11:9–22. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang CX, Sedhom W, Song J and Lu SL: The
role of MicroRNAs in recurrence and metastasis of head and neck
squamous cell carcinoma. Cancers (Basel). 11:3952019. View Article : Google Scholar
|
|
5
|
Eden A and Benvenisty N: Involvement of
branched-chain amino acid aminotransferase (Bcat1/Eca39) in
apoptosis. FEBS Lett. 457:255–261. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ben-Yosef T, Eden A and Benvenisty N:
Characterization of murine BCAT genes: Bcat1, a c-Myc target, and
its homolog, Bcat2. Mamm Genome. 9:595–597. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Garcia-Espinosa MA, Wallin R, Hutson SM
and Sweatt AJ: Widespread neuronal expression of branched-chain
aminotransferase in the CNS: Implications for leucine/glutamate
metabolism and for signaling by amino acids. J Neurochem.
100:1458–1468. 2007.PubMed/NCBI
|
|
8
|
Tonjes M, Barbus S, Park YJ, Wang W,
Schlotter M, Lindroth AM, Pleier SV, Bai AHC, Karra D, Piro RM, et
al: BCAT1 promotes cell proliferation through amino acid catabolism
in gliomas carrying wild-type IDH1. Nat Med. 19:901–908. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang L and Han J: Branched-chain amino
acid transaminase 1 (BCAT1) promotes the growth of breast cancer
cells through improving mTOR-mediated mitochondrial biogenesis and
function. Biochem Biophys Res Commun. 486:224–231. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Raffel S, Falcone M, Kneisel N, Hansson J,
Wang W, Lutz C, Bullinger L, Poschet G, Nonnenmacher Y, Barnert A,
et al: BCAT1 restricts αKG levels in AML stem cells leading to
IDHmut-like DNA hypermethylation. Nature. 551:384–388. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hattori A, Tsunoda M, Konuma T, Kobayashi
M, Nagy T, Glushka J, Tayyari F, McSkimming D, Kannan N, Tojo A, et
al: Cancer progression by reprogrammed BCAA metabolism in myeloid
leukaemia. Nature. 545:500–504. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qi LN, Xiang BD, Wu FX, Ye JZ, Zhong JH,
Wang YY, Chen YY, Chen ZS, Ma L, Chen J, et al: Circulating tumor
cells undergoing EMT provide a metric for diagnosis and prognosis
of patients with hepatocellular carcinoma. Cancer Res.
78:4731–4744. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Z, Jensen MA and Zenklusen JC: A
practical guide to the cancer genome atlas (TCGA). Methods Mol
Biol. 1418:111–141. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rhodes DR, Kalyana-Sundaram S, Mahavisno
V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ,
Kincead-Beal C, Kulkarni P, et al: Oncomine 3.0: Genes, pathways,
and networks in a collection of 18,000 cancer gene expression
profiles. Neoplasia. 9:166–180. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Erxleben A: Mitochondria-targeting
anticancer metal complexes. Curr Med Chem. 26:694–728. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Marbaniang C and Kma L: Dysregulation of
glucose metabolism by oncogenes and tumor suppressors in cancer
cells. Asian Pac J Cancer Prev. 19:2377–2390. 2018.PubMed/NCBI
|
|
18
|
Gu Z, Liu Y, Cai F, Patrick M, Zmajkovic
J, Cao H, Zhang Y, Tasdogan A, Chen M, Qi L, et al: Loss of EZH2
reprograms BCAA metabolism to drive leukemic transformation. Cancer
Discov. 9:1228–1247. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu Y, Yu W, Yang T, Zhang M, Liang C, Cai
X and Shao Q: Overexpression of BCAT1 is a prognostic marker in
gastric cancer. Hum Pathol. 75:41–46. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin X, Tan S, Fu L and Dong Q: BCAT1
overexpression promotes proliferation, invasion, and wnt signaling
in non-small cell lung cancers. Onco Targets Therapy. 13:3583–3594.
2020. View Article : Google Scholar
|
|
21
|
Fortin A, Couture C, Doucet R, Albert M,
Allard J and Tetu B: Does histologic grade have a role in the
management of head and neck cancers? J Clin Oncol. 19:4107–4116.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Economopoulou P, de Bree R, Kotsantis I
and Psyrri A: Diagnostic tumor markers in head and neck squamous
cell carcinoma (HNSCC) in the clinical setting. Front Oncol.
9:8272019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bossi P, Alfieri S, Strojan P, Takes RP,
López F, Mäkitie A, Saba NF, Rodrigo JP, Bradford C, Suarez C, et
al: Prognostic and predictive factors in recurrent and/or
metastatic head and neck squamous cell carcinoma: A review of the
literature. Crit Rev Oncol Hematol. 137:84–91. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fu L, Dong Q, He J, Wang X, Xing J, Wang
E, Qiu X and Li Q: SIRT4 inhibits malignancy progression of NSCLCs,
through mitochondrial dynamics mediated by the ERK-Drp1 pathway.
Oncogene. 36:2724–2736. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guerra F, Arbini AA and Moro L:
Mitochondria and cancer chemoresistance. Biochim Biophys Acta
Bioenerg. 1858:686–699. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim JS, Lee JM, Chwae YJ, Kim YH, Lee JH,
Kim K, Lee TH, Kim SJ and Park JH: Cisplatin-induced apoptosis in
Hep3B cells: Mitochondria-dependent and -independent pathways.
Biochem Pharmacol. 67:1459–1468. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao W, You CC, Zhuang JP, Zu JN, Chi ZY,
Xu GP and Yan JL: Viability inhibition effect of gambogic acid
combined with cisplatin on osteosarcoma cells via
mitochondria-independent apoptotic pathway. Mol Cell Biochem.
382:243–252. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li H, Fu L, Liu B, Lin X, Dong Q and Wang
E: Ajuba overexpression regulates mitochondrial potential and
glucose uptake through YAP/Bcl-xL/GLUT1 in human gastric cancer.
Gene. 693:16–24. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Battogtokh G, Cho YY, Lee JY, Lee HS and
Kang HC: Mitochondrial-Targeting anticancer agent conjugates and
nanocarrier systems for cancer treatment. Front Pharmacol.
9:9222018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Horbay R and Bilyy R: Mitochondrial
dynamics during cell cycling. Apoptosis. 21:1327–1335. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Stockburger C, Miano D, Pallas T,
Friedland K and Muller WE: Enhanced neuroplasticity by the
metabolic enhancer piracetam associated with improved mitochondrial
dynamics and altered permeability transition pore function. Neural
Plast. 2016:80759032016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zambrano A, Molt M, Uribe E and Salas M:
Glut 1 in cancer cells and the inhibitory action of resveratrol as
a potential therapeutic strategy. Int J Mol Sci. 20:33742019.
View Article : Google Scholar
|
|
33
|
Li S, Yang X, Wang P and Ran X: The
effects of GLUT1 on the survival of head and neck squamous cell
carcinoma. Cell Physiol Biochem. 32:624–634. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Osthus RC, Shim H, Kim S, Li Q, Reddy R,
Mukherjee M, Xu Y, Wonsey D, Lee LA and Dang CV: Deregulation of
glucose transporter 1 and glycolytic gene expression by c-Myc. J
Biol Chem. 275:21797–21800. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhou W, Feng X, Ren C, Jiang X, Liu W,
Huang W, Liu Z, Li Z, Zeng L, Wang L, et al: Over-expression of
BCAT1, a c-Myc target gene, induces cell proliferation, migration
and invasion in nasopharyngeal carcinoma. Mol Cancer. 12:532013.
View Article : Google Scholar : PubMed/NCBI
|
